Literature DB >> 9131332

Significance of indeterminate reactivity to human T-cell lymphotropic virus in western blot analysis of individuals at risk.

F J Medrano1, V Soriano, E J Calderón, C Rey, M Gutiérrez, R Bravo, M Leal, J González-Lahoz, E Lissen.   

Abstract

Current tests to confirm human T-cell lymphotropic virus (HTLV) infection in individuals at risk of retroviral infection commonly yield indeterminate results. To assess the significance of HTLV-seroindeterminate reactivities in a high-risk population, 16 at-risk individuals who had this serologic pattern by Western blot were studied using a polymerase chain reaction (PCR) assay. Human T-cell lymphotropic virus type II infection was confirmed by the presence of virus-specific nucleic acid in four patients. However, PCR analysis was negative in the remaining 12 individuals. These results indicate strongly that all specimens from at-risk individuals with nondiagnostic HTLV reactivity by current Western blot assay should continue to be considered inconclusive, requiring further testing by more sensitive tests.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9131332     DOI: 10.1007/bf01709592

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  14 in total

1.  High rate of HTLV-II infection in seropositive i.v. drug abusers in New Orleans.

Authors:  H Lee; P Swanson; V S Shorty; J A Zack; J D Rosenblatt; I S Chen
Journal:  Science       Date:  1989-04-28       Impact factor: 47.728

2.  Failure to detect evidence of human T-lymphotropic virus (HTLV) type I and type II in blood donors with isolated gag antibodies to HTLV-I/II.

Authors:  R B Lal; D L Rudolph; J E Coligan; S K Brodine; C R Roberts
Journal:  Blood       Date:  1992-07-15       Impact factor: 22.113

3.  Endemic human T cell lymphotropic virus type II infection among isolated Brazilian Amerindians.

Authors:  E M Maloney; R J Biggar; J V Neel; M E Taylor; B H Hahn; G M Shaw; W A Blattner
Journal:  J Infect Dis       Date:  1992-07       Impact factor: 5.226

4.  Accelerated loss of antibody to hepatitis B surface antigen among immunodeficient homosexual men infected with HIV.

Authors:  R J Biggar; J J Goedert; J Hoofnagle
Journal:  N Engl J Med       Date:  1987-03-05       Impact factor: 91.245

5.  Evaluation of an immunoblot assay for serological confirmation and differentiation of human T-cell lymphotropic virus types I and II.

Authors:  B D Roberts; S K Foung; J J Lipka; J E Kaplan; K G Hadlock; G R Reyes; L Chan; W Heneine; R F Khabbaz
Journal:  J Clin Microbiol       Date:  1993-02       Impact factor: 5.948

Review 6.  Guidelines for counseling persons infected with human T-lymphotropic virus type I (HTLV-I) and type II (HTLV-II). Centers for Disease Control and Prevention and the U.S.P.H.S. Working Group.

Authors: 
Journal:  Ann Intern Med       Date:  1993-03-15       Impact factor: 25.391

7.  Human T lymphotropic virus type II (HTLV-II) infection in a cohort of New York intravenous drug users: an old infection?

Authors:  R F Khabbaz; D Hartel; M Lairmore; C R Horsburgh; E E Schoenbaum; B Roberts; T M Hartley; G Friedland
Journal:  J Infect Dis       Date:  1991-02       Impact factor: 5.226

8.  Accuracy of supplementary serologic testing for human T-lymphotropic virus types I and II in US blood donors. Retrovirus Epidemiology Donor Study.

Authors:  M P Busch; M Laycock; S H Kleinman; J W Wages; M Calabro; J E Kaplan; R F Khabbaz; C G Hollingsworth
Journal:  Blood       Date:  1994-02-15       Impact factor: 22.113

9.  Loss of antibodies against hepatitis C virus in HIV-seropositive intravenous drug users.

Authors:  E Chamot; B Hirschel; J Wintsch; C F Robert; V Gabriel; J J Déglon; S Yerly; L Perrin
Journal:  AIDS       Date:  1990-12       Impact factor: 4.177

10.  Prevalence of human T-cell leukemia/lymphoma virus (HTLV) type II infection among high-risk individuals: type-specific identification of HTLVs by polymerase chain reaction.

Authors:  G D Ehrlich; J B Glaser; K LaVigne; D Quan; D Mildvan; J J Sninsky; S Kwok; L Papsidero; B J Poiesz
Journal:  Blood       Date:  1989-10       Impact factor: 22.113

View more
  4 in total

1.  Human T-cell lymphotropic virus infection in pregnant women in Spain.

Authors:  C Tuset; M Gutiérrez; C Carbonell; T Tuset; V Soriano
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-10       Impact factor: 3.267

2.  Prevalence of HTLV infection in pregnant women in Spain.

Authors:  A Machuca; C Tuset; V Soriano; E Caballero; A Aguilera; R Ortiz de Lejarazu
Journal:  Sex Transm Infect       Date:  2000-10       Impact factor: 3.519

3.  Can the level of immunosuppression in human immunodeficiency virus-infected patients affect the reliability of human T-cell lymphotropic virus type 2 serological diagnosis?

Authors:  Sylvina Bassani; Carlos Toro; Victoria Jiménez; Berta Rodés; Vincent Soriano
Journal:  Clin Vaccine Immunol       Date:  2006-01

4.  Human T-lymphotropic virus type 1 (HTLV-1) prevalence and quantitative detection of DNA proviral load in individuals with indeterminate/positive serological results.

Authors:  Francesca Vitone; Davide Gibellini; Pasqua Schiavone; Antonietta D'Antuono; Lorenzo Gianni; Isabella Bon; Maria Carla Re
Journal:  BMC Infect Dis       Date:  2006-03-02       Impact factor: 3.090

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.